發(fā)布時間：2018-02-21 14:37

  本文關(guān)鍵詞： 腦出血 微創(chuàng)血腫清除術(shù) 芪紅利水飲 益氣活血 化瘀利水 臨床研究　出處：《河南中醫(yī)學(xué)院》2014年碩士論文　論文類型：學(xué)位論文

【摘要】：目的：比較芪紅利水飲配合微創(chuàng)血腫腫清除術(shù)與微創(chuàng)血腫清除術(shù)治療腦出血的效果及安全性，闡明芪紅利水飲配合微創(chuàng)血腫清除術(shù)的確切療效。 方法：以2011年11月至2014年1月間我科收治的原發(fā)性幕上腦出血患者(30mml~60ml)50例為研究對象，對微創(chuàng)血腫清除術(shù)后患者按照患者或直系親屬意愿進行分組，將患者分為芪紅利水飲配合微創(chuàng)血腫清除術(shù)組（簡稱加中藥組）29例和微創(chuàng)血腫清除術(shù)治療組(簡稱微創(chuàng)組)21例，，比較兩組患者微創(chuàng)血腫清除術(shù)術(shù)后7天后格拉斯哥意識障礙評分(Glasgow coma scale，GCS)，血腫體積變化百分比，中醫(yī)證候評分，對3個月后的生存質(zhì)量行格拉斯哥預(yù)后評分(Glasgowoutcome scale，GOS)并予以分析。 結(jié)果：本項研究中，加中藥組較微創(chuàng)組術(shù)后7天后中藥組的血腫體積顯著縮小，血腫體積變化百分比明顯高于微創(chuàng)組（P0.001），平均GCS評分明顯高于微創(chuàng)組（P0.001），中醫(yī)癥候評分明顯高于微創(chuàng)組（P0.001），但患者長期預(yù)后方面與單用微創(chuàng)血腫清除術(shù)無明顯差異，即二者均可改善患者長期預(yù)后。 結(jié)論：與微創(chuàng)組比較，加中藥組能顯著改善腦出血患者的意識障礙，縮減血腫體積、減輕占位效應(yīng)，改善中醫(yī)癥候評分，但患者長期預(yù)后方面與單用微創(chuàng)血腫抽吸引流術(shù)無明顯差異，即二者均可改善患者長期預(yù)后。
[Abstract]:Objective: to compare the efficacy and safety of Qijianshui decoction combined with minimally invasive hematoma removal and minimally invasive hematoma removal in the treatment of intracerebral hemorrhage, and to elucidate the exact effect of Qijianshui decoction combined with minimally invasive hematoma removal. Methods: 50 patients with primary supratentorial intracerebral hemorrhage treated from November 2011 to January 2014 were divided into groups according to the wishes of the patients or their immediate relatives after minimally invasive hematoma removal. The patients were divided into two groups: Qijiuhuiyin combined with minimally invasive hematoma removal (29 cases) and minimally invasive hematoma removal group (21 cases). Glasgow coma scale scale, hematoma volume change percentage, TCM syndrome score, Glasgow outcome score (Glasgow outcome scale) and Glasgow outcome scale (GOS) were compared between the two groups 7 days after minimally invasive hematoma clearance. Results: in this study, the hematoma volume in the treatment group was significantly smaller than that in the minimally invasive group 7 days after operation. The percentage of hematoma volume change was significantly higher than that in the minimally invasive group (P 0.001), the average GCS score was significantly higher than that in the minimally invasive group (P 0.001), the TCM symptom score was significantly higher than that in the minimally invasive group (P 0.001), but there was no significant difference between the long-term prognosis of the patients and that of minimally invasive hematoma clearance alone. That is, both can improve the long-term prognosis of patients. Conclusion: compared with the minimally invasive group, the traditional Chinese medicine group can significantly improve the disturbance of consciousness, reduce the volume of hematoma, reduce the space occupying effect and improve the score of TCM symptoms in patients with intracerebral hemorrhage. However, there was no significant difference in the long term prognosis between the patients and the minimally invasive hematoma aspiration and drainage alone, that is, both of them could improve the long term prognosis of the patients.
【學(xué)位授予單位】：河南中醫(yī)學(xué)院
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2014
【分類號】：R743.34

【參考文獻】

相關(guān)期刊論文 前10條

1 時曉光;師鏡峰;李超;龐新文;;高血壓腦出血手術(shù)方法及時機對術(shù)后再出血的影響[J];中華神經(jīng)外科疾病研究雜志;2010年02期

2 劉泰;唐宇平;曾祥發(fā);呂晶;;傳統(tǒng)方劑五苓散加減后的2種復(fù)方制劑對血腦屏障保護作用比較(英文)[J];中國臨床康復(fù);2006年15期

3 高巖;張兆輝;;甘露醇對早期高血壓性腦出血繼續(xù)出血影響的Meta分析[J];疑難病雜志;2011年10期

4 張尉華;饒明俐;吳江;張穎;胡利華;;水蛭素對大鼠實驗性腦出血神經(jīng)組織的保護作用[J];中風(fēng)與神經(jīng)疾病雜志;2006年01期

5 劉華;張國平;別曉東;萬海同;樊守燕;杜月光;;通腑活血湯對腦出血大鼠腦組織保護作用的實驗研究[J];中國中藥雜志;2006年06期

6 郭建文,劉明潔;活血化瘀中藥及復(fù)方治療急性腦出血的Meta分析[J];中日友好醫(yī)院學(xué)報;2001年05期

7 李妍;崔向?qū)?陳澤濤;李玉波;;活血化瘀中藥對腦出血大鼠腦組織含水量及AQP4表達的影響[J];中國實驗方劑學(xué)雜志;2011年19期

8 樊鎣;活血化瘀法治療腦出血急性期的臨床與實驗研究進展[J];中國中醫(yī)急癥;1997年03期

9 孫景波;華榮;符文彬;;張學(xué)文教授從顱腦水瘀論治疑難腦病經(jīng)驗[J];中國中醫(yī)急癥;2006年06期

10 謝紀文;從驗案看中醫(yī)獨特臨床研究方法[J];中醫(yī)研究;2005年09期

本文編號：1522139